AnaptysBio announces pricing of $100 million offering

San Diego, USA-based biotech AnaptysBio (Nasdaq: ANAB) yesterday announced the pricing of an underwritten offering of 2,750,498 shares of its common stock at a price of $36.50 per share, representing a premium of approximately 10% to Anaptys’ closing price on August 13, 2024.

AnaptysBio stock initially surged, hitting a five-year high, however, the shares closed up a smaller gain, however, up 4% at 34.65.

The gross proceeds from this offering are expected to be around $100 million, before deducting underwriting discounts, commissions and other offering expenses payable by Anaptys. All of the shares of common stock are being offered by AnaptysBio. The offering is expected to close on or about August 15, 2024, subject to the satisfaction of customary closing conditions.